Ligand Pharmaceuticals Inc SEC filings LGNXZ

Ligand Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Jul 22, 2026 —
S-3ASR Automatic shelf registration Feb 27, 2026 —
S-8 Employee stock plan registration Jul 9, 2024 —
S-8 Employee stock plan registration Mar 1, 2024 —
S-3ASR Automatic shelf registration Sep 30, 2022 —
S-8 Employee stock plan registration Aug 10, 2022 —
S-8 Employee stock plan registration Jun 13, 2022 —
S-8 Employee stock plan registration Jan 27, 2021 —
S-8 Employee stock plan registration Aug 8, 2019 —
S-8 Employee stock plan registration Jul 29, 2016 —
S-3ASR Automatic shelf registration Jan 8, 2016 —

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LGND (Nasdaq), LGNDZ (OTC), LGNXZ (OTC), LGNYZ (OTC), LGNZZ (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
886163
Former names
LIGAND PHARMACEUTICALS (until Sep 13, 1994)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.